|
EP2244709A4
(en)
|
|
Topical formulations for the treatment of psoriasis
|
|
ZA201200016B
(en)
|
|
Topical micro-emulsion for the treatment of rheumatic disorders
|
|
EP2621498A4
(en)
|
|
Combination treatment for dermatological conditions
|
|
GB201202095D0
(en)
|
|
Topical medicament for the treatment of psoriasis
|
|
WO2011143526A9
(en)
|
|
Topical peripheral neuro-affective (tpna) therapy
|
|
WO2011088020A9
(en)
|
|
Modified saponins for the treatment of fungal infections
|
|
IL213851A0
(en)
|
|
Ointment for the topical treatment of haemorrhoids
|
|
IL200753A
(en)
|
|
Pharmaceutical composition comprising ib-meca for the treatment of psoriasis
|
|
IL219298A0
(en)
|
|
Triptans for the treatment of psoriasis
|
|
EP2590651B8
(en)
|
|
New drug combinations for the treatment of malaria
|
|
PT2460509T
(en)
|
|
Composition for the treatment of warts
|
|
GB201011073D0
(en)
|
|
Composition for the treatment of acne vulgaris
|
|
HK1168043A
(en)
|
|
Topical medicament for the treatment of psoriasis
|
|
WO2011097549A9
(en)
|
|
Treatment skin disorders
|
|
AU2010100906A4
(en)
|
|
Skin Disorders Ointment
|
|
AU2010904590A0
(en)
|
|
Treatment Therapy
|
|
HK1163686A
(en)
|
|
Compounds for the treatment of metabolic disorders
|
|
HK1163684A
(en)
|
|
Compounds for the treatment of metabolic disorders
|
|
HK1164882A
(en)
|
|
Compounds for the treatment of metabolic disorders
|
|
HK1189155A
(en)
|
|
Treatment of mecp2-associated disorders
|
|
HK1172281A
(en)
|
|
Compounds for treatment of inflammation
|
|
HK1182092A
(en)
|
|
Arylosulfonamides for the treatment of cns diseases
|
|
AU2010903991A0
(en)
|
|
Nasal Treatment
|
|
HK1169987A
(en)
|
|
Compound suitable for the treatment of synucleopathies
|
|
HK1172319A
(en)
|
|
Therapeutic aryl-am i do-aryl compounds and their use
|